Avacta Group (LON:AVCT) Stock Price Crosses Below 200 Day Moving Average – Here’s What Happened

Avacta Group Plc (LON:AVCT)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 59.32 and traded as low as GBX 54. Avacta Group shares last traded at GBX 54.55, with a volume of 1,327,316 shares.

Wall Street Analysts Forecast Growth

Separately, Peel Hunt reissued a “buy” rating and set a GBX 99 target price on shares of Avacta Group in a research report on Monday, October 13th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of GBX 99.

Avacta Group Stock Down 0.8%

The firm has a market cap of £236.58 million, a price-to-earnings ratio of -3.11 and a beta of 1.12. The firm has a 50 day moving average of GBX 68.78 and a 200 day moving average of GBX 59.32. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 52.53.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).